Trazodone is not FDA-approved for anxiety, but it is widely prescribed off-label to treat it. The FDA approved trazodone specifically for major depressive disorder in adults, and anxiety is not listed anywhere on its official labeling. Despite that, its unique effects on serotonin receptors and other brain systems give it genuine anxiety-reducing properties, and clinical trials back this up. About 69% of patients with generalized anxiety disorder (GAD) experienced moderate to marked improvement on trazodone in a controlled trial, compared to 47% on placebo.
How Trazodone Reduces Anxiety
Trazodone belongs to a class called SARIs (serotonin antagonist and reuptake inhibitors), and it works differently from the SSRIs most people associate with anxiety treatment. It blocks specific serotonin receptors called 5-HT2A and 5-HT2C, which helps regulate mood and anxiety while also increasing the amount of available serotonin in the brain. This dual action is what gives it both antidepressant and anti-anxiety effects.
Beyond serotonin, trazodone also blocks two other receptor types that matter for anxiety. It dampens the body’s fight-or-flight response by blocking alpha-1 adrenergic receptors, which reduces physical anxiety symptoms like racing heart and restlessness. It also blocks histamine receptors, which produces a sedating effect that helps with sleep onset and staying asleep, without the dependence risk that comes with benzodiazepines like diazepam or alprazolam.
What the Clinical Evidence Shows
The strongest evidence for trazodone’s anxiety-reducing effects comes from a landmark randomized, double-blind study that compared it head-to-head against diazepam (a classic anti-anxiety benzodiazepine), imipramine (an older antidepressant), and placebo in 230 patients with GAD. From week 3 through week 8, trazodone matched diazepam’s anxiety relief, and it was actually more effective at treating the psychological symptoms of anxiety, including tension, apprehension, and worry. Imipramine performed slightly better than both.
More recent data on a prolonged-release formulation showed even stronger results. In depressed patients with significant anxiety, trazodone reduced anxiety scores by 42% at 8 weeks, compared to 28% for sertraline (a common SSRI). It also produced meaningful reductions in anxiety symptoms within 1 to 2 weeks of starting treatment. These findings suggest trazodone may be particularly effective when anxiety occurs alongside depression or sleep problems.
Where Trazodone Fits in Anxiety Treatment
Trazodone is not typically a first-line choice for anxiety on its own. Current guidelines position it as a second-line option for generalized anxiety, especially when insomnia is part of the picture or when someone hasn’t tolerated SSRIs well. Its real sweet spot is treating the overlap between anxiety, depression, and sleep disruption, a combination that’s extremely common and that single-target antidepressants often struggle with.
Because trazodone addresses multiple symptom clusters at once, it can sometimes replace the need for a separate sleep medication alongside an anxiety drug. In one study, it improved sleep efficiency by 22% while simultaneously reducing depression and anxiety scores. For people who lie awake at night with a racing mind, this dual benefit is a meaningful advantage.
How Long It Takes to Work
Trazodone’s sedating effects kick in within the first few days, which is why it’s so commonly used as a sleep aid. But the full anti-anxiety and antidepressant effects take longer. You can expect it to start working within 1 to 2 weeks, with the full benefit arriving at 4 to 6 weeks. The NHS recommends giving it at least 6 weeks before judging whether it’s working for you.
Common Side Effects
Drowsiness is the most frequent side effect, affecting about 41% of outpatients in clinical trials compared to 20% on placebo. For people taking trazodone specifically for anxiety with sleep problems, this sedation can actually be welcome, but it can be a problem during the day. Other common side effects include dizziness or lightheadedness (28% of outpatients), dry mouth (34%), and blurred vision (15%). These numbers tend to be higher than placebo but are generally manageable, and many people find they ease up after the first couple of weeks.
One rare but serious side effect that men should know about is priapism, a prolonged, painful erection that requires emergency treatment. This occurs in fewer than 1% of patients, with estimates ranging from 1 in 1,000 to 1 in 10,000 men taking the drug. A broader measure that includes prolonged erections lasting 1 to 4 hours found it in roughly 8% of male patients in one study. Any erection that doesn’t resolve on its own warrants immediate medical attention.
Special Considerations for Older Adults
Trazodone is considered a reasonable option for elderly patients, and guidelines specifically mention it as a choice for older adults with GAD and insomnia. However, it carries some additional risks in this population. The blood pressure drop it causes when standing up (orthostatic hypotension) is more pronounced in older adults, which increases fall risk. Excessive drowsiness can also worsen cognitive function, reduce interest in daily activities, and contribute to oversleeping.
Clinicians typically start older adults at lower doses, often 50 to 75 mg at bedtime, and increase slowly. Many older patients find relief without reaching the higher doses used for depression. Heart rhythm effects are another concern: trazodone can affect the heart’s electrical timing, so it’s generally avoided alongside other medications known to cause similar cardiac effects.
Trazodone vs. Other Anxiety Medications
Compared to benzodiazepines, trazodone takes longer to produce noticeable anxiety relief, but it doesn’t carry the same risk of physical dependence or withdrawal. In the head-to-head GAD trial, dropout rates were the same across all treatments, suggesting people tolerated trazodone about as well as diazepam over 8 weeks, even though the antidepressants caused more side effects overall.
Compared to SSRIs, trazodone’s advantage is its ability to improve sleep without requiring a second medication. SSRIs can actually worsen insomnia in some people, creating a frustrating trade-off. The trade-off with trazodone goes the other direction: it’s more sedating, which is helpful at night but can mean daytime grogginess, especially early in treatment. For anxiety without sleep problems, an SSRI is typically tried first. For anxiety tangled up with poor sleep, trazodone becomes a more compelling option.